13F Notebook
← Dashboard
Fund detail

HHLR Advisors / Hillhouse (Zhang Lei)

china, growth, hillhouse, active

Quarters 30
2021-03-31 $10.12B
Positions 91
Showing 17 of 17 rows (filtered from 108)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 10X GENOMICS INC $0 0 -75,000 -100.00% 0.08%
2 17 ED & TECHNOLOGY GROUP INC $0 0 -4,643,391 -100.00% 0.47%
3 ABCELLERA BIOLOGICS INC $0 0 -600,000 -100.00% 0.19%
4 ALIGN TECHNOLOGY INC $0 0 -182,283 -100.00% 0.77%
5 ATEA PHARMACEUTICALS INC $0 0 -125,000 -100.00% 0.04%
6 ATHENEX INC $0 0 -431,440 -100.00% 0.04%
7 BERKELEY LTS INC $0 0 -200,000 -100.00% 0.14%
8 CELLULAR BIOMEDICINE GROUP I $0 0 -235,214 -100.00% 0.03%
9 CUREVAC N V $0 0 -51,199 -100.00% 0.03%
10 EIDOS THERAPEUTICS INC $0 0 -178,600 -100.00% 0.19%
11 FUTU HLDGS LTD $0 0 -150,000 -100.00% 0.05%
12 G1 THERAPEUTICS INC $0 0 -474,716 -100.00% 0.07%
13 MERCADOLIBRE INC $0 0 -27,525 -100.00% 0.37%
14 SEA LTD $0 0 -337,622 -100.00% 0.53%
15 TAL EDUCATION GROUP $0 0 -4,055,722 -100.00% 2.31%
16 VIELA BIO INC $0 0 -2,382,414 -100.00% 0.68%
17 ZILLOW GROUP INC $0 0 -302,336 -100.00% 0.31%